| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | 4 | — | 2 | — | — | 1 | — |
| Sell | — | — | — | — | 5 | 9 | — | 10 | 1 | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2025 | ‡‡‡ |
|
| 2024 | ‡‡‡ |
|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 264.00 | 141.00 | 120.00 | 163.00 |
| Receivables | 531.00 | 486.00 | 723.00 | 1,167.00 |
| Inventory | 1,197.00 | 1,181.00 | 1,407.00 | 1,877.00 |
| Other | — | 26.00 | 72.00 | 66.00 |
| 1,992.00 | 1,834.00 | 2,322.00 | 3,273.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 1,411.00 | 1,309.00 | 1,674.00 | 2,104.00 |
| ST’ Debt | 41.00 | 39.00 | 39.00 | 42.00 |
| Other | 82.00 | 80.00 | 67.00 | 120.00 |
| 1,556.00 | 1,446.00 | 1,798.00 | 2,290.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2,461.00 | 2,748.00 | — | — |
—
|
| ’25 | 1,979.00 | 2,103.00 | 2,166.00 | 2,201.00 |
8,449.00
|
| ’24 | 1,880.00 | 1,932.00 | 1,802.00 | 1,721.00 |
7,335.00
|
| ’23 | 2,099.57 | 2,126.28 | 1,872.05 | 1,728.10 |
7,826.00
|
| ’22 | 2,220.83 | 2,421.06 | 2,036.56 | 1,876.79 |
8,555.23
|
| ’21 | 1,616.71 | 1,829.04 | 1,871.39 | 1,961.29 |
7,278.43
|
| ’20 | 1,585.30 | 1,135.23 | 1,370.07 | 1,487.25 |
5,577.85
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 73.00 | 161.00 | — | — |
—
|
| ’25 | 58.00 | 114.00 | 99.00 | 218.00 |
489.00
|
| ’24 | 37.00 | 138.00 | 65.00 | 61.00 |
301.00
|
| ’23 | 36.50 | 145.60 | 167.28 | 82.62 |
432.00
|
| ’22 | 65.09 | 114.76 | 145.48 | 149.85 |
475.17
|
| ’21 | 90.42 | 87.91 | 103.50 | 140.54 |
422.37
|
| ’20 | 158.86 | 8.51 | 140.08 | 74.08 |
381.53
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.00 | 84.00 | — | — |
—
|
| ’25 | (11.00) | 37.00 | 24.00 | 109.00 |
159.00
|
| ’24 | (37.00) | 54.00 | (39.00) | (90.00) |
(112.00)
|
| ’23 | (37.57) | 73.55 | 84.83 | (54.81) |
66.00
|
| ’22 | 28.06 | 62.40 | 69.69 | 27.40 |
187.54
|
| ’21 | 51.84 | 37.32 | 41.73 | 17.00 |
147.89
|
| ’20 | 95.98 | (36.52) | 91.34 | 22.83 |
173.63
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.42 | 1.04 | — | — |
—
|
| ’25 | 0.26 | 0.25 | 0.62 | 0.80 |
1.92
|
| ’24 | 0.12 | 0.52 | 0.02 | (0.34) |
0.38
|
| ’23 | 0.15 | 0.23 | 0.47 | 0.08 |
0.91
|
| ’22 | 1.35 | (0.26) | 0.89 | 0.20 |
2.17
|
| ’21 | 0.39 | 0.88 | 0.77 | 0.06 |
2.07
|
| ’20 | (0.24) | (0.26) | 0.15 | 0.20 |
(0.17)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 9.82 | 11.76 | 9.95 | 7.33 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 20.85 | 20.68 | 23.20 | 19.38 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12,500 | 12,000 | 12,000 | 11,500 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.68 | 0.65 | 0.61 | 0.73 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8,555.23 | 7,826.00 | 7,335.00 | 8,449.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.28% | 13.48% | 12.79% | 14.05% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 213.88 | 232.00 | 135.00 | 408.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.50% | 2.96% | 1.84% | 4.83% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 324.51 | 157.00 | 60.00 | 275.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 302.38 | 300.00 | 304.00 | 330.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 59.57 | 53.56 | 50.34 | 60.49 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 2.21 | 0.92 | 0.38 | 1.95 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 3.31 | 2.96 | 2.07 | 3.50 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.00) | (2.50) | (2.83) | (2.36) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.31 | 0.45 | (0.77) | 1.14 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.52 | 5.08 | 4.99 | 6.95 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 143.63 | 146.13 | 145.72 | 139.68 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 5.39 | 20.84 | 32.09 | 9.62 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.20 | 0.37 | 0.20 | 0.31 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 2.20 | 3.86 | 2.06 | 2.71 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.43 | 0.58 | 0.45 | 0.53 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.73 | 68.60 | (29.23) | 28.03 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 475.17 | 432.00 | 301.00 | 489.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (287.63) | (366.00) | (413.00) | (330.00) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 187.54 | 66.00 | (112.00) | 159.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 382.46 | 436.00 | 388.00 | 524.00 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,166.20 | 1,929.00 | 1,918.00 | 1,944.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,958.64 | 1,665.00 | 1,777.00 | 1,824.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 792.31 | 742.00 | 727.00 | 971.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.94% | 3.00% | 1.16% | 5.41% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.00% | 8.91% | 6.14% | 11.56% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 55.80% | 19.81% | 7.62% | 32.16% | — | — | — |
ROE
|
Constellium SE (CSTM), a key player in specialty aluminum for aerospace, automotive, and packaging, has shown notable resilience through commodity cycles and disruptions, transforming a once-weak balance sheet with steady deleveraging—reducing net debt 30% since 2016—and positive equity growth to $727 million by 2024. Despite revenue peaking at $8.56 billion in 2022 before a 6% dip to $7.34 billion amid normalizing prices and European energy costs, operational efficiency shines through, with revenue per employee up 28% from 2016 levels and gross margins rebounding 54% to 12.8%. Free cash flow turned negative in 2024 due to elevated capex for sustainable facilities, a prudent but liquidity-testing move in a capital-intensive sector.
Analyst forecasts signal a robust rebound, with revenue projected to climb 15% to $8.45 billion in 2025 and 31% cumulatively by 2027, driven by aerospace backlogs (Airbus, Boeing) and EV demand for lightweight components, alongside EPS surging 542% to $2.44. Valuation appears reasonable at 0.45x EV/Sales versus growth prospects, with stock highs resilient above $20 despite recent softness, hinting at market anticipation of catalysts like margin expansion and ROIC recovery to 8-9%.
Yet risks persist: aluminum oversupply from China, U.S. tariffs, and EU energy volatility could cap upside, echoing past margin erosions from trade wars. With muted insider activity and a constructive yet measured outlook, CSTM merits watching for Q1 2025 cash flows and aerospace orders to confirm its steady-performer potential amid electrification tailwinds.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.